Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

September 02, 2015 7:11 AM ET


Company Overview of Amplimmune, Inc.

Company Overview

Amplimmune, Inc. develops immune-based biologics to treat patients in the areas of cancer, autoimmunity, transplantation, and infectious diseases. The company’s biologics are co-stimulatory/co-inhibitory molecules that rebalance the immune system. Its products include AMP-110, a therapeutic candidate that targets T-cells and elicits a coinhibitory signal, which suppresses T-cell responses for the treatment of autoimmune/inflammatory disorders and transplantation; and AMP-224, a fusion protein that blocks the interaction between PD-1 and B7-H1 for treatment of cancer and chronic infections. Amplimmune, Inc. has a strategic alliance and partnership with GlaxoSmithKline. The company was incorpo...

45 West Watkins Mill Road

Gaithersburg, MD 20878

United States

Founded in 2006





Key Executives for Amplimmune, Inc.

Chief Executive Officer, President and Director
Age: 54
Scientific Founder and Board Observer
Scientific Founder
Scientific Founder and Board Observer
Scientific Founder
Compensation as of Fiscal Year 2015.

Similar Private Companies By Industry

Company Name Region
Surfacine Development Company LLC United States
MesoBio LLC United States
Femta Pharmaceuticals, Inc. United States
Exemplar Genetics LLC United States
Rockwall Holdings, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Amplimmune, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at